A&G PHARMACEUTICAL, INC

Basic Information

9130 RED BRANCH RD STE U
COLUMBIA, MD, 21045-2006

http://www.agpharma.com

Company Profile

A&G Pharmaceutical discovers, develops, and commercializes innovative personalized medicine products that improve screening, monitoring, and targeted treatment of cancer and other human diseases. A&G’s Precision Antibody service division (www.precisionantibody.com) generates revenue to fund the drug development and diagnostic efforts by providing customized antibodies to leading pharmaceutical and biotechnology companies as well as federal laboratories. A&G Pharmaceutical is located in Columbia, MD.

Additional Details

Field Value
DUNS: 963442723
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 27


  1. IGF OT IGF SMART FUSION HIGH AFFINITY PEPTIDE CAPTURE REAGENTS

    Amount: $1,000,000.00

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of HealthDepartment of Health and Human Services
  2. Title: Development of Novel Anticancer Agent to potentiate sensitivity to anti-estrogen therapy PoP: 09/19/2014 to 09/18/2016

    Amount: $1,478,552.00

    Not Available

    SBIR Phase II 2014 Department of Health and Human Services
  3. IGF::OT::IGF Title: SMART Fusion: High Affinity Peptide Capture Reagents PoP: 0

    Amount: $199,828.00

    The purpose of this application is to develop realiable, renewable, cost effective, specific, high affinity antipeptide affitnity reagent to be successfully used in mass spec based cancer biomarker de ...

    SBIR Phase I 2013 Department of Health and Human Services
  4. Targeted Therapy for Non Small Cell Lung Carcinoma: In vivo Feasibility Studies

    Amount: $193,879.00

    DESCRIPTION (provided by applicant): Lung Cancer remains the leading cause of cancer and mortality for men and women worldwide. In 2010, there were 222,520 new cases of lung cancer diagnosed in t ...

    SBIR Phase I 2012 Department of Health and Human Services
  5. NOVEL AGENT TO RESTORE SENSITIVITY TO ANTI-ESTROGEN THERAPY

    Amount: $199,380.00

    Aromatase Inhibitors (AI) are the preferred hormonal treatment for estrogen receptor positive Breast Cancer (BC) in postmenopausal women and are used to treat approximately 140,000 patients annually i ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Serum GP88 biomarker as a surrogate marker for disease progression in breast canc

    Amount: $113,320.00

    DESCRIPTION (provided by applicant): 40,000 women die annually in the US as a result of breast cancer (BC). Although BC can be controlled if detected early, a significant number is not detected until ...

    SBIR Phase I 2011 Department of Health and Human Services
  7. Novel Targeted Therapy for Breast Cancer

    Amount: $1,153,870.00

    DESCRIPTION (provided by applicant): Breast cancer remains one of the top three cancers to affect and cause mortality in women. Major shortcomings with current treatment are the high level of side eff ...

    SBIR Phase II 2010 Department of Health and Human Services
  8. Novel Small Molecule Inhibitor of Rheumatoid Arthritis

    Amount: $184,029.00

    DESCRIPTION (provided by applicant): Lck is a Src family non-receptor tyrosine kinase expressed by T lineage lymphocytes. In T cells, Lck plays an essential role in the generation of antigen-mediated ...

    SBIR Phase I 2009 Department of Health and Human Services
  9. Novel Targeted Therapy for Breast Cancer

    Amount: $120,600.00

    DESCRIPTION (provided by applicant): Breast cancer remains one of the top three cancers to affect and cause mortality in women. Major shortcomings with current treatment are the high level of side eff ...

    SBIR Phase I 2007 Department of Health and Human Services
  10. Development of a novel serum diagnosis for breast cancer

    Amount: $99,960.00

    DESCRIPTION (provided by applicant): Each year 200,000 women in the US are diagnosed with breast cancer, and 40,000 women will die of the disease. Serum diagnosis for screening breast cancer patients ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government